Population-Based Study of the Relationship Between Patent Foramen Ovale and Cerebrovascular Ischemic Events

Petty, George W.; Khandheria, Buoy K.; Meissener, Irene; Whisnant, Jack P.; Rocca, Walter A.; Christianson, Teresa J. H.; Sicks, JoRean D.; O'Fallon, W. Michael; McClelland, Robyn L.; Wiebers, David O.
May 2006
Mayo Clinic Proceedings;May2006, Vol. 81 Issue 5, p602
Academic Journal
OBJECTIVE: To determine whether patent foramen ovale (PFO) is a risk factor for a cryptogenic cerebrovascular ischemic event (CIE). METHODS: This case-control study of 1072 residents of Olmsted County, Minnesota, who underwent contrast transesophageal echocardiography between 1993 and 1997 included 519 controls without CIE randomly selected from the population, 262 controls without CIE referred for transesophageal echocardiography because of cardiac disease, 158 cases with incident CIE of obvious cause (noncryptogenic), and 133 cases with incident CIE of uncertain cause (cryptogenic). RESULTS: Large PFOs were detected in 108 randomly selected controls (20.8%), 22 referred controls (8.4%), 17 noncryptogenic CIE cases (10.8%), and 22 cryptogenic CIE cases (16.5%). After adjustment for age, sex, hypertension, smoking, atrial fibrillation, ischemic heart disease, and number of contrast injections, the presence of a large PFO was not significantly associated with group status (P=.07). Using the odds of the presence of large PFO in the randomly selected controls as the reference, the odds ratio (95% confidence interval) of the presence of large PFO was 0.47 (0.26-0.87) for referred controls, 0.69 (0.37-1.29) for noncryptogenic CIE cases, and 1.10 (0.63-1.90) for cryptogenic CIE cases. CONCLUSIONS: Patent foramen ovale is not a risk factor for cryptogenic ischemic stroke or transient ischemic attack in the general population. The PFO's importance in the genesis of cryptogenic CIE may have been overestimated in previous studies be cause of selective referral of cases and underascertainment of PFO among comparison groups of patients referred for echocardiography for clinical indications other than cryptogenic CIE.


Related Articles

  • Population-Based Study of the Relationship Between Atherosclerotic Aortic Debris and Cerebrovascular Ischemic Events. Petty, George W.; Khandheria, Buoy K.; Meissner, Irene; Whisnant, Jack P.; Rocca, Walter A.; Sicks, JoRean D.; Christianson, Teresa J. H.; O'Fallon, W. Michael; McCklelland, Robyn L.; Wiebers, David O. // Mayo Clinic Proceedings;May2006, Vol. 81 Issue 5, p609 

    OBJECTIVE: To assess the validity of the suggestion that protruding atheromatous material in the thoracic aorta is an important cause of cerebrovascular lschemic events (CIEs) (ie, transient ischemic attack or ischemic stroke). METHODS: This case-control study of Olmsted County, Minnesota,...

  • Transesophageal echocardiography in patients with cryptogenic cerebral ischemia. Knebel, Fabian; Masuhr, Florian; von Hausen, Wolfram; Walde, Torsten; Dreger, Henryk; Raab, Vanessa; Yuerek, Mahsun; Baumann, Gert; Borges, Adrian C. // Cardiovascular Ultrasound;2009, Vol. 7, Special section p1 

    Background: In about one third of all patients with cerebral ischemia, no definite cause can be identified (cryptogenic stroke). In many patients with initially suspected cryptogenic stroke, however, a cardiogenic etiology can eventually be determined. Hence, the aim of this study was to...

  • How to reliably detect ischemia in the intensive care unit and operating room. Shanewise, Jack S. // Seminars in Cardiothoracic & Vascular Anesthesia;Mar2006, Vol. 10 Issue 1, p101 

    Detection of myocardial ischemia in the perioperative period is important because it allows for intervention that may prevent progression of ischemia to myocardial infarction. Perioperative ischemia is also an important predictor of adverse cardiovascular outcomes. Patients should first be...

  • Multimodal Detection of Perioperative Myocardial Ischemia. Mark, Jonathan B.; Nussmeier, Nancy A. // Texas Heart Institute Journal;2005, Vol. 32 Issue 4, p461 

    Cardiac anesthesiologists have the responsibility to detect myocardial ischemia in a timely manner, which can be a challenging task in the perioperative environment. Transesophageal echocardiography, pulmonary artery catheterization, and electrocardiography are the 3 major methods available for...

  • Classification system for stratification of stroke risk. SADOVSKY, RICHARD // American Family Physician;10/15/1998, Vol. 58 Issue 6, p1420 

    Presents the abstract of the article `Usefulness of transesophageal echocardiography in predicting mortality and morbidity in stroke patients without clinically known cardiac sources of embolus,' by P.J. O'Brien, et al from `American Journal of Cardiology' dated May 1, 1998.

  • Utility of Transesophageal Echocardiography in Determining the Source of Arterial Embolization. Mariano, Myron C.; Gutierrez, Charles J.; Alexander, Jason Q.; Katz, Steven G.; Kohl, Roy D.; Roth, Fernando // American Surgeon;Sep2002, Vol. 68 Issue 9, p765 

    Arterial embolism is frequently the product of a cardiac source. Arterial-arterial embolization and paradoxical embolization also occur. Failure to identify the point of origin may subject the patient to an important incidence of preventable events. Conventional echocardiography is insensitive...

  • Echocardiography in stroke: Which probe when? Thompson, Christopher R. // CMAJ: Canadian Medical Association Journal;10/19/99, Vol. 161 Issue 8, p981 

    Editorial. Comments on the use of echocardiograms to identify a possible cardiac source of brain embolism. Focus on a review on the issue by the Canadian Task Force on Preventive Health Care; Controversy over the use of transesophageal echocardiography as the initial screening test;...

  • Transesophageal echocardiography is a valuable diagnostic... Dale, David C.; Federman, Daniel D. // Cortlandt Forum;12/20/97, Vol. 10 Issue 12, p17 

    Reports the major contribution of the transesophageal echocardiography (TEE) to the assessment of stroke risks in patients with atrial fibrillation.

  • Accuracy of transesophageal echocardiography for identifying left atrial thrombi. Manning, Warren J.; Weintraub, Ronald M. // Annals of Internal Medicine;12/1/95, Vol. 123 Issue 11, p817 

    Determines the ability of transesophageal echocardiography to accurately identify or exclude left atrial thrombi. Explanation of two-dimensional echocardiography technique; Impact of the introduction of the transesophageal echocardiography technique on the field of clinical medicine; Procedures...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics